Abstract:Introduction Cholestasis, as a common liver injury in clinic, increases the risk of other malignant hepatobiliary diseases such as hepatic carcinoma and cholangiocarcinoma. Estrogen‐induced cholestasis occurred in many susceptible women due to pregnancy or hormone therapy. Previous studies from our group and others suggest that AMP‐activated protein kinase (AMPK) induced phosphorylation of farnesoid X receptor (FXR), a key nuclear receptor involved in regulating bile acid homeostasis represents an important underlying mechanism of estrogen‐induced cholestasis. Most recent clinical study indicated that ursodeoxycholic acid (UDCA) monotherapy is effective in the treatment of intrahepatic cholestasis of pregnancy. However, the functional molecular/cellular mechanisms of UDCA‐mediated protective effect against estrogen‐induced cholestasis remains unclear and is the focus of this study. Methods The sandwich‐cultured rat primary hepatocytes and 17α‐ethinylestradiol (EE)‐induced rat cholestasis models were used. The protein levels were determined by Western blot analysis. The mRNA levels of targeted genes were determined by real‐time RT‐PCR. Immunofluorescent staining was used to detect canalicular structure of liver. Results EE significantly suppressed the expression of FXR and bile acid transporters via activation of AMPK signaling pathways. In rat primary hepatocytes, UDCA significantly inhibited EE‐induced AMPK activation and down‐regulation of FXR and bile acid transporters. UDCA rapidly and dose‐dependently induced phosphorylation of protein kinase A (PKA), which was correlated to its effect on inhibition of EE‐induced AMPK activation and down‐regulation of FXR expression. H89, a PKA inhibitor, blocked UDCA‐induced inhibitory effect on EE‐induced AMPK activation and downregulation of FXR and bile acid transporters. Furthermore, UDCA inhibited EE‐induced AMPK activation and downregulation of FXR and bile acids transporters in vivo rat cholestasis models. Conclusion UDCA protected hepatocytes from EE‐induced cholestatic injury via inhibiting AMPK activation. Our data also suggested that activation of PKA may also contribute to UDCA‐mediated protective effects. Support or Funding Information This poster presentation was supported by the Fundamental Research Funds for the Central Universities. And this study was supported by National Natural Science Foundation of China Grants (81320108029).

Estradiol-17beta-D-glucuronide induces endocytic internalization of Bsep in rats

Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17β-D-glucuronide-induced cholestasis: complementarity with classical protein kinase C

Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver

ERK1/2 and p38 MAPKs are complementarily involved in estradiol 17ß-D-glucuronide-induced cholestasis: crosstalk with cPKC and PI3K

Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats

Tauroursodeoxycholate prevents estradiol 17β-d-glucuronide-induced cholestasis and endocytosis of canalicular transporters by switching off pro-cholestatic signaling pathways

Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury

Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2

Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes

Sandwich-cultured rat hepatocytes as an in vitro model to study canalicular transport alterations in cholestasis

Emodin Rescues Intrahepatic Cholestasis Via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile

Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition

Differential effects of membrane cholesterol content on the transport activity of multidrug resistance-associated protein 2 (ABCC2) and of the bile salt export pump (ABCB11)

Multidrug Resistance-Associated Protein 2 Deficiency Aggravates Estrogen-Induced Impairment of Bile Acid Metabolomics in Rats

UDCA Prevents 17α‐Ethinylestradiol‐induced Cholestatic Injury via Inhibiting AMP‐activated Protein Kinase Activation

Transport of Bile Acids, Sulfated Steroids, Estradiol 17- -D-Glucuronide, and Leukotriene C4 by Human Multidrug Resistance Protein 8 (ABCC11)

Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions

Efflux Excretion of Bisdemethoxycurcumin‐o‐glucuronide in UGT1A1‐overexpressing HeLa Cells: Identification of Breast Cancer Resistance Protein (BCRP) and Multidrug Resistance‐associated Proteins 1 (MRP1) As the Glucuronide Transporters

Role of AMP-activated Protein Kinase Α1 in 17Α-Ethinylestradiol-induced Cholestasis in Rats.

ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3)

Degradation of the Bile Salt Export Pump at Endoplasmic Reticulum in Progressive Familial Intrahepatic Cholestasis Type II